Pharmaceutical Partnering and Alliances
Japanese Drug Company Bids for U.S. Biotech Firm
The $25-a-share deal, announced Thursday, represented a 53 percent premium to Millennium's closing price Wednesday, and it immediately set off speculation that...
Date:
04/11/2008
, Publication:
NY TIMES
, Author:
ANDREW POLLACK
http://www.nytimes.com/2008/04/11/business/worldbusiness/11drug.html?ref=health
Drug company ties common in med schools
Two-thirds of academic leaders have financial links to industry, study says
Date:
10/16/2007
, Publication:
MSNBC
, Author:
Associated Press
http://www.msnbc.msn.com/id/21333262/
Tibotec Gets AIDS
With a new wave of "resistant to resistance" HIV drugs, a record of consistent innovation, and a dynamic partnership with AIDS activists, J&J's little company is in it to win it. And end it.
Date:
07/30/2007
, Publication:
Pharmaceutical Executive
, Author:
Walter Armstrong
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=446937
Deals: Roche Goes Shopping
BioVeris purchase locks in a key diagnostic technology. PLUS: Eisai buys Morphotek, IMS gets more outcomes-research muscle, and other top deals.
Date:
05/01/2007
, Publication:
Pharmaceutical Executive
, Author:
Pharmaceutical Executive
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=423197
Critical Mass for Critical Path?
...the rewards of collaboration now look greater than the risks....
Date:
05/01/2007
, Publication:
Pharmaceutical Executive
, Author:
Dan Weiner, Mark Hovde
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=423202
Make It New
To fix pharma's business model, nothing less than big, bold, and risky fits the bill. Two radical new visions focus on getting back to...
Date:
05/01/2007
, Publication:
Pharmaceutical Executive
, Author:
Walter Armstrong
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=418775
Toolkit: How To Be a Better Partner
Big pharmas and little biotechs have been getting hitched for years. Now it's time to add a little innovation to the relationship.
Date:
05/01/2007
, Publication:
Pharmaceutical Executive
, Author:
Waseem Noor
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=423200
Thought Leader: Joseph Brindisi, Kyowa Pharmaceuticals
Rethinking Partnership
Date:
03/01/2007
, Publication:
Pharmaceutical Executive
, Author:
Pharmaceutical Executive
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=408470
Merger and Acquisition Drivers Remain in Place for 2007
Deals will continue to remake the pharmaceutical services landscape in 2007.
Date:
02/01/2007
, Publication:
Pharmaceutical Technology
, Author:
Jim Miller
http://www.pharmtech.com/pharmtech/article/articleDetail.jsp?id=400648
Driven to License
The new trend in business development is licensing deals and acquisitions. The hot categories are CNS, oncology, and immunology.
Date:
02/01/2007
, Publication:
Pharmaceutical Executive
, Author:
Ben Bonifant, Michael Dombeck, Alex Lugovoy
http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=401667
Previous
Page 1 of 10
Next >
Search returned 97 items.
|
Sponsored Links
Medical Marketing & Media is a monthly
to 14,000 healthcare marketing executives
www.medicalmarketingandmedia.com
This twice-monthly news magazine
reports on all phases of pharmacy
www.drugtopics.com
|